Philip Morris (PM.US) officially launched its IQOS heated tobacco device in Austin, Texas on Thursday, priced at $60 with tobacco sticks at $8 per pack. The world's largest cigarette maker aims to capture 10% of the U.S. tobacco and heated tobacco market by 2030 as it enters what it considers the top global market for smoking alternatives.
Regulatory and Marketing Approach
"We're offering IQOS at a lower price compared to other markets to build appetite among new consumers," said Francisca Rahardja, PMI's marketing chief for inhalables. The company is showcasing the product at the Austin MotoGP and has deployed "IQOS coaches" at adult-only venues. PM is currently selling an older FDA-approved IQOS version while awaiting authorization for its latest iteration, ILUMA, having announced only the Austin launch so far despite earlier plans for expansion to four cities.
Philip Morris (D1 Interval)
The stock price is approaching a short-term resistance level at $155.65. Bears may aim to retest the 30-day EMA, which coincides with the 23.6% Fibonacci retracement level. The RSI is in bearish divergence with lower highs, while the MACD is tightening toward a potential bullish divergence.
Daily wrap – US Export Restrictions on China and Weaker Earnings Trigger Wall Street Correction
Google Quantum Echoes – A Quantum Computing Breakthrough
Those Stocks Scared Investors Ahead Of This Halloween🎃 — Market Losers of 2025
IBM Earnings Preview: Will grandfather of IT industry deliver expectations?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
